Hydroxyurea (HU) is commonly used for the long-term treatment of patients with chronic myeloproliferative neoplasms. The drug is usually well tolerated in the large majority of subjects, although systemic and/or localized toxicities have seldom been reported. Here we report a case of unusual cutaneous toxicity due longterm use of HU in a patient with polycythemia vera.
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CASE REPORT
Unusual cutaneous toxicity after prolonged use of Hydroxyurea in polycythemia vera: a case report Elisa Molinari MD [1] , Gianfranco Barabino MD [2] , Eleonora Arboscello MD [1] , Lisette Del Corso MD [1] , Andrea Bellodi MD [1] , Vera Sicbaldi MD [1] , Serena Favorini MD [1] , Riccardo Ghio MD [1] , and Enrico Balleari MD [1] . Serious cutaneous adverse events include skin cancer and ulcers. These latter lesions are however rare, and even rarer are the localization on hands and head. Here we report a case of unusual and late cutaneous toxicity due to HU observed in our Center.
Introduction
Case presentation
In November 2010 a 86 years old man was firstly seen in our outpatient Clinic because of polyglobulia. The patient was complaining for intense pruritus since a few . In our case, the localization of ulcers in sunexposed areas, also suggests the possible role of a photosensitivity to HU. This form of skin damage is very rarely seen after exposure to HU; to the best of our knowledge, only two previous cases of ulcers on sunexposed areas such as heels, forearms and hands have been described 6, 7 . This aspect suggests the possibility of 
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